macroprolactinoma

出典: meddic

マクロプロラクチノーマ

microprolactinomaPRL-secreting pituitary adenomaprolactin-secreting pituitary adenomaprolactinoma

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
  • Rastogi A1, Bhadada SK1, Bhansali A1.
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.Gynecol Endocrinol.2016 Dec 2:1-4. [Epub ahead of print]
  • Hyperprolactinemia and prolactinomas cause infertility in significant number of women. But, pregnancy may lead to post-partum remission of hyperprolactinemia. The data on pregnancy and tumor outcome in women with macroprolactinoma conceiving on Cabergoline (CAB) therapy is increasing but still less
  • PMID 27908214
  • Long-term outcome of macroprolactinomas.
  • Képénékian L1, Cebula H2, Castinetti F3, Graillon T4, Brue T3, Goichot B5.
  • Annales d'endocrinologie.Ann Endocrinol (Paris).2016 Dec;77(6):641-648. doi: 10.1016/j.ando.2016.07.004. Epub 2016 Sep 15.
  • OBJECTIVE: Management of macroprolactinomas has dramatically changed in recent decades, from surgical to medical treatment as first-line therapy, with the development of dopamine agonists (DA). But few data exist on the long-term outcome of these patients.PATIENTS AND METHODS: Retrospective descript
  • PMID 27641080
  • Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.
  • Sala E1, Bellaviti Buttoni P2, Malchiodi E2, Verrua E2, Carosi G2, Profka E2, Rodari G2, Filopanti M2, Ferrante E2,3, Spada A2, Mantovani G2.
  • Journal of endocrinological investigation.J Endocrinol Invest.2016 Dec;39(12):1377-1382. Epub 2016 May 31.
  • BACKGROUND: The optimal duration of cabergoline (CAB) treatment of prolactinomas that minimizes recurrences is not well established. 2011 Endocrine Society Guidelines suggested that withdrawal may be safely undertaken after 2 years in patients achieving normoprolactinemia and tumor reduction.MATERI
  • PMID 27245604

和文文献

関連リンク

関連画像


押しても画像が表示されない場合はサーバが混雑しています。2週間ほどあけて、再度押下してください。


★リンクテーブル★
先読みprolactinoma
リンク元prolactin-secreting pituitary adenoma」「PRL-secreting pituitary adenoma」「マクロプロラクチノーマ」「microprolactinoma

prolactinoma」

  [★] プロラクチン産生腺腫プロラクチノーマ

prolactin-secreting pituitary adenoma」

  [★] プロラクチン産生下垂体腺腫プロラクチン分泌下垂体腺腫プロラクチノーマ

macroprolactinomamicroprolactinomaPRL-secreting pituitary adenomaprolactinoma

PRL-secreting pituitary adenoma」

  [★] プロラクチン産生下垂体腺腫プロラクチン分泌下垂体腺腫

macroprolactinomamicroprolactinomaprolactin-secreting pituitary adenomaprolactinoma

マクロプロラクチノーマ」

  [★]

macroprolactinoma
プロラクチノーマプロラクチン分泌下垂体腺腫ミクロプロラクチノーマプロラクチン産生下垂体腺腫


microprolactinoma」

  [★]

ミクロプロラクチノーマ

macroprolactinomaPRL-secreting pituitary adenomaprolactin-secreting pituitary adenomaprolactinoma




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡